Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?

Abstract excerpt

Several recent pharmacogenetic studies have investigated the variability in both outcome and toxicity in cisplatin-based therapies. These studies have focused on the genetic variability of therapeutic targets that could affect cisplatin response and toxicity in diverse type of cancer including lung, gastric, ovarian, testicular, and esophageal cancer. In this review, we seek to update the reader in this area of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer therapeutics and mechanisms
• Share to Chemotherapy-induced organ toxicity mitigation
• Share to DNA Repair Mechanisms